Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 19 | 2023 | 10905 | 1.570 |
Why?
|
Exercise Tolerance | 8 | 2023 | 770 | 1.180 |
Why?
|
Sex Characteristics | 5 | 2023 | 2586 | 1.110 |
Why?
|
Infertility | 2 | 2023 | 655 | 1.080 |
Why?
|
Stroke Volume | 15 | 2023 | 5008 | 1.060 |
Why?
|
Sex Factors | 10 | 2023 | 10396 | 0.980 |
Why?
|
Purinergic P2Y Receptor Antagonists | 2 | 2017 | 361 | 0.960 |
Why?
|
Menopause, Premature | 1 | 2023 | 132 | 0.830 |
Why?
|
Cardiovascular Diseases | 8 | 2024 | 15161 | 0.800 |
Why?
|
Early Termination of Clinical Trials | 1 | 2021 | 68 | 0.770 |
Why?
|
Pulmonary Edema | 2 | 2021 | 414 | 0.760 |
Why?
|
Pheochromocytoma | 1 | 2021 | 337 | 0.660 |
Why?
|
Drug Therapy | 1 | 2021 | 497 | 0.620 |
Why?
|
Menopause | 2 | 2023 | 1626 | 0.600 |
Why?
|
Exercise Test | 8 | 2023 | 2075 | 0.580 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2018 | 183 | 0.560 |
Why?
|
Inflammation Mediators | 2 | 2022 | 1889 | 0.540 |
Why?
|
Mitral Valve Stenosis | 1 | 2018 | 376 | 0.540 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2021 | 740 | 0.530 |
Why?
|
Blood Coagulation Disorders | 1 | 2018 | 337 | 0.520 |
Why?
|
Blood Proteins | 1 | 2019 | 1123 | 0.490 |
Why?
|
Women | 1 | 2016 | 230 | 0.480 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2018 | 501 | 0.470 |
Why?
|
Muscle Fatigue | 1 | 2013 | 83 | 0.450 |
Why?
|
Ventricular Function, Left | 8 | 2023 | 3669 | 0.450 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1869 | 0.450 |
Why?
|
Respiratory Muscles | 1 | 2013 | 140 | 0.450 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2013 | 104 | 0.440 |
Why?
|
Albuterol | 1 | 2013 | 208 | 0.430 |
Why?
|
Blood Coagulation | 1 | 2018 | 1127 | 0.420 |
Why?
|
Acidosis, Lactic | 1 | 2013 | 142 | 0.420 |
Why?
|
Physicians, Women | 1 | 2018 | 486 | 0.400 |
Why?
|
Cardiology | 2 | 2023 | 1668 | 0.390 |
Why?
|
Aspirin | 1 | 2022 | 3282 | 0.380 |
Why?
|
Hypertension | 5 | 2023 | 8480 | 0.370 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2021 | 264 | 0.370 |
Why?
|
Obesity | 7 | 2023 | 12742 | 0.340 |
Why?
|
Proteomics | 2 | 2022 | 3637 | 0.330 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5034 | 0.320 |
Why?
|
Myocardium | 1 | 2021 | 4776 | 0.310 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3227 | 0.300 |
Why?
|
Phenotype | 2 | 2021 | 16365 | 0.290 |
Why?
|
Risk Factors | 14 | 2023 | 72280 | 0.280 |
Why?
|
Cardiomyopathies | 1 | 2018 | 1913 | 0.280 |
Why?
|
Inflammation | 4 | 2023 | 10634 | 0.270 |
Why?
|
Female | 35 | 2024 | 380197 | 0.270 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 1965 | 0.270 |
Why?
|
Insulin Resistance | 5 | 2023 | 3863 | 0.260 |
Why?
|
Humans | 49 | 2024 | 744220 | 0.260 |
Why?
|
Eicosanoids | 2 | 2023 | 279 | 0.250 |
Why?
|
Middle Aged | 23 | 2023 | 213367 | 0.250 |
Why?
|
Dyspnea | 2 | 2023 | 1303 | 0.240 |
Why?
|
Adrenomedullin | 1 | 2023 | 87 | 0.230 |
Why?
|
Coronary Artery Disease | 3 | 2018 | 6489 | 0.220 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3533 | 0.220 |
Why?
|
Anticoagulants | 1 | 2018 | 4599 | 0.220 |
Why?
|
Hemodynamics | 4 | 2021 | 4199 | 0.220 |
Why?
|
Ventricular Remodeling | 3 | 2023 | 1224 | 0.200 |
Why?
|
Hematemesis | 1 | 2021 | 23 | 0.200 |
Why?
|
Hierarchy, Social | 1 | 2021 | 23 | 0.200 |
Why?
|
Leptospirosis | 1 | 2021 | 29 | 0.190 |
Why?
|
Hypertension, Pulmonary | 2 | 2023 | 1536 | 0.190 |
Why?
|
Adiponectin | 3 | 2023 | 1100 | 0.190 |
Why?
|
C-Reactive Protein | 3 | 2021 | 3778 | 0.180 |
Why?
|
Male | 26 | 2023 | 350027 | 0.180 |
Why?
|
Blood Sedimentation | 1 | 2020 | 231 | 0.180 |
Why?
|
Risk Reduction Behavior | 2 | 2017 | 1125 | 0.180 |
Why?
|
Hemoptysis | 1 | 2021 | 155 | 0.180 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11728 | 0.170 |
Why?
|
Verbal Behavior | 1 | 2021 | 339 | 0.170 |
Why?
|
Electrocardiography | 4 | 2023 | 6442 | 0.170 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.160 |
Why?
|
Atrial Function, Right | 1 | 2018 | 33 | 0.160 |
Why?
|
Leptin | 3 | 2023 | 1599 | 0.160 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2024 | 489 | 0.160 |
Why?
|
Pulmonary Gas Exchange | 1 | 2020 | 382 | 0.160 |
Why?
|
Abortion, Induced | 1 | 2024 | 458 | 0.160 |
Why?
|
Adipokines | 1 | 2020 | 319 | 0.150 |
Why?
|
Cardiac Volume | 1 | 2018 | 210 | 0.150 |
Why?
|
Lung | 3 | 2021 | 9852 | 0.150 |
Why?
|
Respiratory Function Tests | 1 | 2021 | 1618 | 0.140 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 782 | 0.140 |
Why?
|
Interleukin-6 | 3 | 2023 | 3201 | 0.140 |
Why?
|
Aged | 13 | 2023 | 163253 | 0.140 |
Why?
|
Fatal Outcome | 1 | 2021 | 1849 | 0.140 |
Why?
|
Cardiovascular System | 1 | 2024 | 832 | 0.140 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2022 | 531 | 0.140 |
Why?
|
Shock, Cardiogenic | 1 | 2021 | 688 | 0.130 |
Why?
|
Logistic Models | 2 | 2021 | 13409 | 0.130 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 552 | 0.130 |
Why?
|
Adult | 17 | 2023 | 214035 | 0.130 |
Why?
|
Primary Prevention | 1 | 2022 | 1167 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2023 | 1072 | 0.130 |
Why?
|
Radiography, Thoracic | 1 | 2021 | 1265 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1200 | 0.120 |
Why?
|
Pregnancy | 5 | 2024 | 29142 | 0.120 |
Why?
|
Patient Preference | 1 | 2021 | 887 | 0.120 |
Why?
|
Internal Medicine | 1 | 2021 | 1009 | 0.110 |
Why?
|
Health Services Research | 1 | 2021 | 1836 | 0.110 |
Why?
|
Mitral Valve Insufficiency | 1 | 2023 | 1421 | 0.110 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15538 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5755 | 0.110 |
Why?
|
Women's Health | 1 | 2022 | 2034 | 0.110 |
Why?
|
Linear Models | 2 | 2020 | 5953 | 0.100 |
Why?
|
Heart Atria | 1 | 2018 | 1356 | 0.100 |
Why?
|
Adiposity | 1 | 2021 | 1807 | 0.100 |
Why?
|
Massachusetts | 2 | 2021 | 8663 | 0.100 |
Why?
|
Cardiovascular Agents | 1 | 2017 | 850 | 0.090 |
Why?
|
Administration, Inhalation | 1 | 2013 | 1104 | 0.090 |
Why?
|
Longitudinal Studies | 2 | 2023 | 13990 | 0.090 |
Why?
|
Risk | 1 | 2022 | 9685 | 0.090 |
Why?
|
Outpatients | 1 | 2018 | 1486 | 0.090 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1458 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2022 | 3278 | 0.090 |
Why?
|
Quality of Life | 2 | 2022 | 12805 | 0.090 |
Why?
|
Blood Pressure | 2 | 2022 | 8551 | 0.090 |
Why?
|
Prognosis | 4 | 2023 | 29050 | 0.080 |
Why?
|
Education, Medical | 1 | 2021 | 1721 | 0.080 |
Why?
|
Anti-Retroviral Agents | 1 | 2018 | 1715 | 0.080 |
Why?
|
Echocardiography | 2 | 2018 | 5103 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2018 | 2796 | 0.080 |
Why?
|
Curriculum | 1 | 2021 | 3604 | 0.080 |
Why?
|
MicroRNAs | 1 | 2023 | 3747 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2023 | 3444 | 0.070 |
Why?
|
Prospective Studies | 6 | 2022 | 53280 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2022 | 63119 | 0.070 |
Why?
|
Coronary Vessels | 1 | 2017 | 3107 | 0.070 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1519 | 0.070 |
Why?
|
Coronary Angiography | 1 | 2017 | 4578 | 0.070 |
Why?
|
Registries | 1 | 2021 | 8090 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 3068 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10262 | 0.060 |
Why?
|
Mortality | 1 | 2016 | 2864 | 0.060 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2024 | 70 | 0.060 |
Why?
|
Epoxy Compounds | 1 | 2023 | 136 | 0.060 |
Why?
|
Resistin | 1 | 2023 | 170 | 0.050 |
Why?
|
Linoleic Acid | 1 | 2023 | 157 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6773 | 0.050 |
Why?
|
Internship and Residency | 1 | 2021 | 5787 | 0.050 |
Why?
|
Plasmapheresis | 1 | 2021 | 212 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9960 | 0.050 |
Why?
|
Bundle-Branch Block | 1 | 2022 | 270 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15070 | 0.040 |
Why?
|
Live Birth | 1 | 2023 | 512 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15294 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3047 | 0.040 |
Why?
|
Mexico | 1 | 2021 | 690 | 0.040 |
Why?
|
Videoconferencing | 1 | 2021 | 195 | 0.040 |
Why?
|
American Heart Association | 1 | 2023 | 1056 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12961 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2023 | 77426 | 0.040 |
Why?
|
Signal Transduction | 1 | 2021 | 23404 | 0.040 |
Why?
|
Communication Barriers | 1 | 2021 | 398 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 441 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 23337 | 0.040 |
Why?
|
Odds Ratio | 2 | 2020 | 9849 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2021 | 764 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2008 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2021 | 862 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 2021 | 1470 | 0.030 |
Why?
|
Travel | 1 | 2021 | 788 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2024 | 12264 | 0.030 |
Why?
|
Mitral Valve | 1 | 2023 | 1490 | 0.030 |
Why?
|
Emigrants and Immigrants | 1 | 2021 | 522 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 1130 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1614 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39045 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1199 | 0.030 |
Why?
|
Incidence | 2 | 2022 | 20945 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2022 | 2267 | 0.030 |
Why?
|
HIV Infections | 1 | 2018 | 16718 | 0.030 |
Why?
|
Body Mass Index | 2 | 2020 | 12718 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1814 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3509 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3478 | 0.020 |
Why?
|
Triglycerides | 1 | 2018 | 2453 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2213 | 0.020 |
Why?
|
Cholesterol | 1 | 2018 | 2911 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2291 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7183 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5316 | 0.020 |
Why?
|
Patient Compliance | 1 | 2017 | 2684 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13280 | 0.020 |
Why?
|
Exercise | 1 | 2022 | 5615 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 57768 | 0.020 |
Why?
|
Blood Glucose | 1 | 2018 | 6259 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12355 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3842 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7179 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 3923 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 56436 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2023 | 17449 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15226 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40559 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20123 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40063 | 0.010 |
Why?
|
United States | 1 | 2023 | 69867 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 85759 | 0.010 |
Why?
|
Concepts
(198)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(100)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_